Senior insider sale
VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$267.7K
584.00 shares
What this filing means
BHATIA SANGEETA N. plans to sell 584.00 shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $267.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/4/2026ACC: 0001959173-26-003218
Director
Since Oct 2018
584.00
Shares to sell
$267.7K
Approx. market value
318.00
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
5/1/2026
318.00Total acquired318.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/1/2026 | Restricted Stock Vesting Compensation | 318.00 | — |
| Total | 318.00 | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
266.00
Market value
$133.0K
2/13/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
318.00
Market value
$134.7K
5/4/2026
Total
Units
584.00
Value
$267.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/13/2026 | 266.00 | $133.0K | — | Completed |
| Planned — Approximate Date | ||||
5/4/2026 | 318.00 | $134.7K | NASDAQ | Planned |
| Total | 584.00 | $267.7K | ||